Tech Ticker: Gilead, eBay, Qualcomm
San Jose Mercury News Gilead Sciences (GILD) said Wednesday it signed a licensing deal with MicroDose Therapeutx for an experimental respiratory virus treatment. The deal focuses on MDT-637 for respiratory syncytial virus, or RSV, the leading cause of infant hospitalization … |
More: continued here